These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 7483733

  • 1. [Prognostic relevance of hepatitis C virus genotype for responsiveness to interferon-alpha].
    Berg T, König V, Küther S, Heuft HG, Wittmann G, Lobeck H, Hopf U.
    Z Gastroenterol; 1995 Aug; 33(8):426-30. PubMed ID: 7483733
    [Abstract] [Full Text] [Related]

  • 2. Treatment of chronic hepatitis C with interferon alpha: long-term follow-up and prognostic relevance of HCV genotypes.
    Hopf U, Berg T, König V, Küther S, Heuft HG, Lobeck H.
    J Hepatol; 1996 Aug; 24(2 Suppl):67-73. PubMed ID: 8836892
    [Abstract] [Full Text] [Related]

  • 3. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C.
    Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, Degott C, Descombes I, Le Breton V, Milotova V.
    Hepatology; 1995 Oct; 22(4 Pt 1):1050-6. PubMed ID: 7557850
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
    Weiland O, Chen M, Lindh G, Mattsson L, Schvarcz R, Sönnerborg A, Wahl M, Wejstål R, Widell A, Norkrans G.
    Scand J Infect Dis; 1995 Oct; 27(5):319-24. PubMed ID: 8588128
    [Abstract] [Full Text] [Related]

  • 5. Prospective comparison of four lymphoblastoid interferon alpha schedules for chronic hepatitis C. A multivariate analysis of factors predictive of sustained response to treatment.
    Bellobuono A, Mondazzi L, Tempini S, Silini E, Idéo G.
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1169-77. PubMed ID: 9471022
    [Abstract] [Full Text] [Related]

  • 6. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.
    Olaso V, Córdoba J, Berenguer M, Prieto M, Lainez B, Argüello L, Valverde J, Pascual S, Gobernado M, Berenguer J.
    Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839
    [Abstract] [Full Text] [Related]

  • 7. Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.
    Mamori S, Suzuki F, Hosaka T, Akuta N, Someya T, Kobayashi M, Tsubota A, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Kumada H.
    J Gastroenterol; 2004 Aug; 39(8):776-82. PubMed ID: 15338372
    [Abstract] [Full Text] [Related]

  • 8. Sustained remission and viraemia in chronic hepatitis C treated with recombinant alpha-interferon (rIFN-alpha).
    Bresci G, Gambardella L, Parisi G, Banti S, Scatena F, Bertoni M, Capria A.
    Int J Clin Pharmacol Res; 1995 Aug; 15(5-6):175-9. PubMed ID: 8835615
    [Abstract] [Full Text] [Related]

  • 9. Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy.
    Kurosaki M, Enomoto N, Murakami T, Sakuma I, Asahina Y, Yamamoto C, Ikeda T, Tozuka S, Izumi N, Marumo F, Sato C.
    Hepatology; 1997 Mar; 25(3):750-3. PubMed ID: 9049230
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
    Weiland O, Chen M, Lindh G, Mattsson L, Schvarcz R, Sönnerborg A, Wahl M, Wejstål R, Widell A, Norkrans G.
    Scand J Infect Dis; 1995 Mar; 27(4):319-24. PubMed ID: 8658063
    [Abstract] [Full Text] [Related]

  • 11. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
    Chuang WL, Dai CY, Chang WY, Lee LP, Lin ZY, Chen SC, Hsieh MY, Wang LY, Yu ML.
    Antivir Ther; 2005 Mar; 10(1):125-33. PubMed ID: 15751770
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of prolonged interferon therapy for patients with chronic hepatitis C with HCV-genotype 1b and high virus load.
    Arase Y, Ikeda K, Tsubota A, Suzuki Y, Saitoh S, Kobayashi M, Kobayashi M, Suzuki F, Akuta N, Someya T, Kumada H.
    J Gastroenterol; 2003 Mar; 38(2):158-63. PubMed ID: 12640530
    [Abstract] [Full Text] [Related]

  • 13. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y, Bayraktar M, Gurakar A, Hassanein TI, Van Thiel DH.
    Hepatogastroenterology; 1997 Mar; 44(14):417-25. PubMed ID: 9164512
    [Abstract] [Full Text] [Related]

  • 14. Response to interferon-based therapies in HIV-infected patients with chronic hepatitis C due to genotype 4.
    Soriano V, Núñez M, Sánchez-Conde M, Barreiro P, García-Samaniego J, Martín-Carbonero L, Romero M, González-Lahoz J.
    Antivir Ther; 2005 Mar; 10(1):167-70. PubMed ID: 15751774
    [Abstract] [Full Text] [Related]

  • 15. Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients.
    Missale G, Cariani E, Lamonaca V, Ravaggi A, Rossini A, Bertoni R, Houghton M, Matsuura Y, Miyamura T, Fiaccadori F, Ferrari C.
    Hepatology; 1997 Sep; 26(3):792-7. PubMed ID: 9303515
    [Abstract] [Full Text] [Related]

  • 16. [Long-term therapy in chronic hepatitis C with recombinant alpha interferon].
    Siciliano R, Trovato BA, Romano M, Pantò A, Seminara G, Malaguarnera M.
    Riv Eur Sci Med Farmacol; 1994 Sep; 16(3-4):73-8. PubMed ID: 7480963
    [Abstract] [Full Text] [Related]

  • 17. Alpha interferon treatment in chronic hepatitis C.
    Idéo G, Bellobuono A, Mondazzi L, Tempini S, Bellati G, Idéo GM, Silini E.
    Clin Exp Rheumatol; 1995 Sep; 13 Suppl 13():S167-73. PubMed ID: 8730501
    [Abstract] [Full Text] [Related]

  • 18. [Long-term treatment of cryptogenic hepatitis C using recombinant interferon alpha].
    Hopf U, Möller B, König V, Küther S, Lobeck H, Huhn D.
    Z Gastroenterol; 1990 Sep; 28(9):453-7. PubMed ID: 2125776
    [Abstract] [Full Text] [Related]

  • 19. [HCV-serotype and IFN response].
    Nakamura H, Kako M, Aikawa T, Mayumi M, Kanai K.
    Nihon Rinsho; 1994 Jul; 52(7):1734-7. PubMed ID: 7521412
    [Abstract] [Full Text] [Related]

  • 20. Clinico-pathological predictive factors of response to interferon therapy in chronic hepatitis C.
    Thavarungkul P, Toriyama K, Kusuda M, Kamito H, Kamito M, Nakayama T, Kato Y, Itakura H.
    Southeast Asian J Trop Med Public Health; 1996 Mar; 27(1):85-90. PubMed ID: 9031407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.